Kimberly Bowron Sells 25,101 Shares of Gevo (NASDAQ:GEVO) Stock

Key Points

• Gevo insider Kimberly Bowron sold 25,101 shares at an average price of $1.76, totaling about $44,178. The sale was part of a pre-arranged Rule 10b5-1 plan and was used to cover tax withholding obligations tied to vested equity awards.
• Gevo recently reported weaker-than-expected quarterly results, posting a loss of $0.05 per share versus the $0.02 loss expected and revenue of $42.95 million versus $44.90 million expected. Analysts still project the company will remain unprofitable this fiscal year.
• Analyst views remain mixed: HC Wainwright raised earnings estimates and kept a Buy rating, while other firms issued Sell or Neutral ratings. MarketBeat says the stock currently carries a consensus Hold rating with a $6.50 price target.

Gevo, Inc. (NASDAQ:GEVO - Get Free Report) insider Kimberly Bowron sold 25,101 shares of the business's stock in a transaction that occurred on Wednesday, May 27th. The stock was sold at an average price of $1.76, for a total value of $44,177.76. Following the transaction, the insider directly owned 711,765 shares in the company, valued at approximately $1,252,706.40. This trade represents a 3.41% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Gevo Stock Performance

NASDAQ GEVO traded down $0.04 during trading on Friday, reaching $1.86. 2,501,313 shares of the company's stock were exchanged, compared to its average volume of 3,669,851. Gevo, Inc. has a fifty-two week low of $1.10 and a fifty-two week high of $2.97. The business has a 50 day moving average price of $1.99 and a 200-day moving average price of $2.03. The company has a debt-to-equity ratio of 0.37, a current ratio of 4.31 and a quick ratio of 3.51. The stock has a market capitalization of $452.74 million, a P/E ratio of -14.31 and a beta of 1.00.

Gevo (NASDAQ:GEVO - Get Free Report) last issued its quarterly earnings results on Thursday, May 7th. The energy company reported ($0.05) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by ($0.03). The company had revenue of $42.95 million during the quarter, compared to the consensus estimate of $44.90 million. Gevo had a negative net margin of 19.38% and a negative return on equity of 5.06%. Sell-side analysts forecast that Gevo, Inc. will post -0.11 earnings per share for the current fiscal year.

More Gevo News

Here are the key news stories impacting Gevo this week:

• Positive Sentiment: HC Wainwright lifted its earnings outlook for Gevo, including higher EPS estimates for Q2 2026, Q3 2026, FY2026, FY2027, FY2028, FY2029 and FY2030, while maintaining a Buy rating. This suggests analysts see better earnings potential ahead for Read More..
• Neutral Sentiment: Gevo was also the subject of an article comparing its financial profile with Clearway Energy, but that type of relative valuation coverage is unlikely to move the stock on its own. Article Title
• Neutral Sentiment: Short-interest data showed no meaningful change in reported short interest, with the latest figure still at zero shares, so this does not appear to be a real trading catalyst for the stock.
• Negative Sentiment: Despite the analyst upgrades, Gevo’s recent earnings history remains a headwind: the company previously missed quarterly EPS and revenue estimates, and analysts still expect a loss for the current fiscal year. That helps explain why the stock may still be trading below recent averages.

Analyst Ratings Changes

Several equities research analysts recently issued reports on GEVO shares. Northland Securities set a $3.50 price target on Gevo and gave the company an "outperform" rating in a research note on Thursday, April 16th. Weiss Ratings restated a "sell (d-)" rating on shares of Gevo in a research note on Tuesday, April 21st. Zacks Research cut Gevo from a "hold" rating to a "strong sell" rating in a research note on Friday, May 8th. HC Wainwright restated a "buy" rating on shares of Gevo in a research note on Tuesday. Finally, UBS Group restated a "neutral" rating and set a $2.00 target price (down from $2.25) on shares of Gevo in a research note on Friday, May 22nd. Two investment analysts have rated the stock with a Buy rating, one has given a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $6.50.

Institutional Inflows and Outflows

A number of hedge funds have recently bought and sold shares of GEVO. Millennium Management LLC grew its stake in Gevo by 1.9% in the 1st quarter. Millennium Management LLC now owns 3,278,261 shares of the energy company's stock valued at $3,803,000 after buying an additional 61,919 shares in the last quarter. Goldman Sachs Group Inc. lifted its holdings in shares of Gevo by 11.8% during the 1st quarter. Goldman Sachs Group Inc. now owns 1,164,499 shares of the energy company's stock worth $1,351,000 after acquiring an additional 123,170 shares during the last quarter. JPMorgan Chase & Co. lifted its stake in Gevo by 915.8% in the second quarter. JPMorgan Chase & Co. now owns 121,305 shares of the energy company's stock worth $160,000 after purchasing an additional 109,363 shares during the last quarter. Legal & General Group Plc bought a new stake in Gevo in the second quarter worth $28,000. Finally, Rhumbline Advisers bought a new stake in Gevo in the second quarter worth $383,000. 35.17% of the stock is currently owned by hedge funds and other institutional investors.

About Gevo

Gevo, Inc NASDAQ: GEVO is a renewable chemicals and biofuels company that develops and produces low-carbon alternatives to petroleum-based products. The company's core technology platform converts fermentable sugars into isobutanol, which can be further processed into sustainable aviation fuel (SAF), renewable gasoline, diesel, and jet fuel. Gevo's integrated biorefinery model combines fermentation, recovery, and downstream processing to deliver scalable, drop-in replacements for conventional fossil-derived hydrocarbons.

Gevo's primary products include isobutanol, a four-carbon alcohol used as a building block for various fuels and chemicals, and hydrocarbon fuels that meet ASTM specifications for aviation and road transport.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.